Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Oral, Multiple-dose, Parallel, Randomized Study to Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients With Acute Mania Episodes With or Without Mixed Features

NCT06608641 is registered in ClinicalTrials.gov with Jina Pharmaceuticals Inc. as lead sponsor.

NCT NCT06608641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06608641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Oral, Multiple-dose, Parallel, Randomized Study to Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients With Acute Mania Episodes With or Without Mixed Features
Lead sponsor
Jina Pharmaceuticals Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 19, 2024
Completion date
December 31, 2025
Enrollment
490 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar 1 disorder